Rapport Therapeutics Inc....

14.38
0.61 (4.43%)
At close: Jan 28, 2025, 1:58 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22
Revenue n/a n/a
Cost of Revenue 112.00K 15.00K
Gross Profit -112.00K -15.00K
Operating Income -36.18M -10.37M
Interest Income 2.53M n/a
Pretax Income -34.78M -10.65M
Net Income -34.79M -10.65M
Selling & General & Admin 8.07M 1.24M
Research & Development 28.00M 9.12M
Other Expenses n/a n/a
Operating Expenses 36.07M 10.35M
Interest Expense n/a 285.00K
Selling & Marketing Expenses -112.00K n/a
Cost & Expenses 36.18M 10.37M
Income Tax 10.00K n/a
Shares Outstanding (Basic) 164.35M 36.58M
Shares Outstanding (Diluted) 164.35M 36.58M
EPS (Basic) -0.21 -0.29
EPS (Diluted) -0.21 -0.29
EBITDA -34.66M -10.35M
Depreciation & Amortization 112.00K 15.00K